www.reportscorner.com Reports Corner has added “Global Pharmaceutical Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry” to its latest reports offering. lease visit the link (https://www.reportscorner.com/report_detail.php?r_id=9824 )

1. www.reportscorner.com
Reports Corner has added “Global Pharmaceutical Survey 2013-2014 - Market Trends, Marketing
Spend and Sales Strategies in the Global Pharmaceutical Industry” to its latest reports offering.
lease visit the link (https://www.reportscorner.com/report_detail.php?r_id=9824 )
Product Synopsis
“Global Pharmaceutical Survey 2013-2014: Market Trends, Marketing Spend and Sales Strategies in
the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how
pharmaceutical industry companies' media spend, marketing and sales strategies and practices, and
business planning are set to change in 2013-2014. Additionally, this report also presents
comparative analysis between four years of survey results (wherever applicable). This report
provides the current size of the marketing and advertising budgets of global pharmaceutical
industry suppliers and how spending by global pharmaceutical industry suppliers will change,
providing an insight into global marketing behaviour. In addition, the report identifies future
growth of global pharmaceutical industry buyers and suppliers and MandA activity. This report not
only grants access to the opinions and strategies of business decision makers and competitors, but
also examines their actions surrounding business priorities. The report also provides access to
information categorized by region, company type and sizes.”
Introduction and Landscape
Why was the report written?
This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading
global pharmaceutical industry executives. The report provides data and analysis on global
pharmaceutical industry suppliers' media spend, marketing and sales strategies, and practices and
business planning within the global pharmaceutical industry. This report includes key topics such as
media channel spending outlooks, media budgets, marketing agency selection criteria, business
challenges, and sales tactics of leading suppliers within the global pharmaceutical industry. The
report also identifies global pharmaceutical industry buyers' and suppliers' future growth, MandA
and investment expectations. Most secondary research reports are based on general industry drivers
and do not understand the industry executives' attitude and changing behaviours, creating a gap in
presenting the business outlook of the industry. In an effort to bridge this gap, ICD Research
created this primary-research based report by gathering the opinions of multiple stake holders in
the value-chain of the global pharmaceutical industry
What is the current market landscape and what is changing?
The average size of the annual marketing budget of global pharmaceutical industry supplier
respondents stood at US$4.2 million in 2012, a figure that decreased to US$2.6 million in 2013.
What are the key drivers behind recent market changes?
In the process of choosing marketing agencies, the 'ability to target specific audience niches',
'strategic and tactical consulting', and the 'ability to generate leads or setup customer meetings' are
considered the most important factors by global pharmaceutical industry suppliers.
What makes this report unique and essential to read?

2. This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading
pharmaceutical industry companies. This report provides the reader with a definitive analysis of the
industry outlook and explores how opportunities and demand are set to change in 2013-2014.
Additionally, this report also presents comparative analysis between four years of survey results
(wherever applicable). Furthermore, the report reveals the current size of pharmaceutical industry
suppliers' marketing and advertising budgets and how expenditure by industry suppliers will change,
providing insight into global marketing behavior. This report identifies the key marketing aims of
organizations and the sales strategies companies will adopt in order to adapt to market conditions
in 2013. Additionally, this chapter also aims to identify key amendments to marketing agencies that
aid business generation, respondents' criteria for marketing agency selection, and attitudes towards
marketing and sales.
Key Features and Benefits
Projects industry trends and revenue growth expectations in 2013.
Drive revenues by understanding future product investment areas and key growth regions.
Uncover key challenges and opportunities and identify key actions required to maintain and win
buyer business.
Formulate effective sales and marketing strategies by identifying the overall size of the marketing
budgets of global pharmaceutical industry supplier companies.
Identifies the key marketing aims of organizations and which sales strategies companies will be
adopting to deal with market conditions in 2013-2014.
Key Market Issues
China, Brazil, and India are the important emerging markets to offer growth in 2013.
'Market uncertainty', 'responding to price pressure', 'rising competition', and 'regulatory changes' are
the leading business concerns for the global pharmaceutical industry in 2013.
The average size of the annual marketing budget of global pharmaceutical industry supplier
respondents stood at US$4.2 million in 2012, a figure that decreased to US$2.6 million in 2013.
'Social media and networking sites', 'email and newsletters', and 'conferences and events' are
expected to have increased expenditure in 2013 as identified by 56%, 48%, and 44% of respondents
respectively.
Overall, 'competitor and market intelligence research', 'customer intelligence and analytics', and
'business performance management solutions' were identified as the marketing and sales solutions
most expected to be invested in during 2013.
Key Highlights
An analysis of revenue growth expectations by senior level respondents reveals that 62% are 'more
optimistic' about their company's revenue growth in 2013.
A significant percentage of pharmaceutical manufacturing industry respondents highlighted that
capital expenditure towards 'new product development', 'employee training', and 'IT infrastructure
development' would increase in 2013.
The top three priorities for global pharmaceutical industry buyer respondents in 2013 are 'new
products and services', 'improve operational efficiency', and 'expand in current markets'.

3. A total of 49% of respondents from pharmaceutical manufacturing companies, 68% of respondents
from CRO and CMO companies, and 64% of respondents from pharmaceutical industry supplier
companies anticipate an increase in their current workforce in 2013.
Survey results show that respondents from the global pharmaceutical industry identified the US as
offering the highest growth potential among developed countries in 2013-2014.
Table of Contents
1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Global pharmaceutical industry: profile of buyer respondents
1.4.2 Global pharmaceutical industry: profile of supplier respondents
2 Executive Summary
3 Global Pharmaceutical Industry Dynamics
3.1 Revenue Growth Projections in the Global Pharmaceutical Industry
3.1.1 Revenue growth projections by company type
3.1.2 Revenue growth projections by region
3.1.3 Revenue growth projections by company turnover
3.1.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents
3.2 Future Developments in Business Structure in the Global Pharmaceutical Industry
3.2.1 Future developments in business structure by buyers
3.2.2 Future developments in business structure by suppliers
3.2.3 Future developments in business structure by region
3.2.4 Future developments in business structure by company turnover
3.2.5 Future developments in business structure by senior level respondents
3.3 Change in Leading Company Strategies in the Global Pharmaceutical Industry
3.3.1 Change in leading company strategies by buyers
3.3.2 Change in leading company strategies by suppliers
3.3.3 Change in leading company strategies by region
3.3.4 Change in leading company strategies by company turnover
3.4 Merger and Acquisition (MandA) Activity Projections in the Global Pharmaceutical Industry
3.4.1 MandA activity projections by buyers
3.4.2 MandA activity projections by suppliers
3.4.3 MandA activity projections by region
3.4.4 MandA activity projections by company turnover
3.4.5 MandA activity projections by purchasing decision authority
3.4.6 Global pharmaceutical industry - expand abroad Vs MandA activity projections
3.5 Estimation of Capital Expenditure in the Global Pharmaceutical Industry
3.5.1 Estimation of capital expenditure by buyers
3.5.2 Estimation of capital expenditure by suppliers
3.5.3 Estimation of capital expenditure by region
3.5.4 Estimation of capital expenditure by company turnover
3.6 Planned Change in Staff Recruitment Activity in the Global Pharmaceutical Industry
3.6.1 Planned change in staff recruitment activity by buyers
3.6.2 Planned change in staff recruitment activity by suppliers
3.6.3 Planned change in staff recruitment activity by region
3.6.4 Planned change in staff recruitment activity by company turnover

4. 4 Global Pharmaceutical Industry Market Growth Outlook
4.1 Global Pharmaceutical Industry: Demand in Emerging Markets
4.1.1 Demand in emerging markets by buyers
4.1.2 Demand in emerging markets by suppliers
4.1.3 Demand in emerging markets by region
4.1.4 Demand in emerging markets by company turnover
4.2 Global Pharmaceutical Industry - Growth Projections in Developed Countries
4.2.1 Growth projections in developed countries by buyers
4.2.2 Growth projections in developed countries by suppliers
4.2.3 Growth projections in developed countries by region
4.2.4 Growth projections in developed countries by company turnover
5 Threats and Opportunities for the Global Pharmaceutical Industry
5.1 Global Pharmaceutical Industry: Leading Business Concerns for 2013-2014
5.1.1 Leading business concerns for 2013-2014 by company type
5.1.2 Leading business concerns for 2013-2014 by region
5.1.3 Leading business concerns for 2013-2014 by company turnover
5.2 Global Pharmaceutical Industry: Key Supplier Actions to Maintain and Win Buyer Business
5.2.1 Actions to maintain and secure buyer business by buyers
5.2.2 Actions to maintain and secure buyer business by region
5.2.3 Actions to maintain and secure buyer business by company turnover
5.2.4 Actions to maintain and secure buyer business by purchasing decision authority
6 Global Pharmaceutical Industry - Supplier Marketing Spend Activity
6.1 Annual Marketing Budgets - Global Pharmaceutical Industry Suppliers
6.1.1 Annual marketing budgets by region - global pharmaceutical industry suppliers
6.1.2 Annual marketing budgets by company turnover - global pharmaceutical industry suppliers
6.2 Planned Change in Marketing Expenditure Levels - Global Pharmaceutical Industry Suppliers
6.2.1 Planned change in marketing expenditure by region - global pharmaceutical industry suppliers
6.2.2 Planned change in marketing expenditure by turnover - global pharmaceutical industry
suppliers
6.2.3 Planned change in marketing expenditure by decision making authority - global
pharmaceutical industry suppliers
6.2.4 Planned change in marketing expenditure levels vs. revenue growth expectations (%), 2013
6.3 Future Investment by Media Channel - Global Pharmaceutical Industry Suppliers
6.3.1 Future investment by media channel by region - global pharmaceutical industry suppliers
6.3.2 Future investment by media channel by company turnover - global pharmaceutical industry
suppliers
6.4 Global Pharmaceutical Industry Suppliers' Future Investment in Marketing and Sales
6.4.1 Planned investment in marketing and sales technologies by region - global pharmaceutical
industry suppliers
6.4.2 Planned investment in marketing and sales by turnover: global pharmaceutical industry
suppliers
7 Marketing and Sales Behaviors and Strategies in 2013-2014
7.1 Key Marketing Aims for 2013-2014 - Global Pharmaceutical Industry Suppliers
7.1.1 Key marketing aims by region - global pharmaceutical industry suppliers
7.1.2 Key marketing aims by company turnover - global pharmaceutical industry suppliers
7.2 Essential Amendments to Marketing Activities in 2013-2014
7.2.1 Amendments to marketing activities by company turnover - global pharmaceutical industry
suppliers
7.3 Critical Success Factors for Choosing a Marketing Agency
7.3.1 Critical success factors for choosing a marketing agency by region

5. 7.3.2 Critical success factors by company turnover - global pharmaceutical industry suppliers
8 Appendix
8.1 Global Pharmaceutical Industry Survey Results- Closed Questions
8.2 Methodology
8.3 Contact us
8.4 About ICD Research
8.5 Disclaimer
Table of Contents
Table 1: Global Pharmaceutical Industry Survey Respondents by Company Type, 2013
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2013
Table 3: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2013
Table 4: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2013
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2013
Table 6: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2013
Table 7: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2013
Table 8: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010-2013
Table 9: Revenue Growth Optimism in the Global Pharmaceutical Industry by Buyers (%), 2010-2013
Table 10: Revenue Growth Optimism in the Global Pharmaceutical Industry by Suppliers (%), 2010-
2013
Table 11: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%),2013
Table 12: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013
Table 13: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry
(%), 2013
Table 14: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry
(%), 2013
Table 15: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry
(%), 2013
Table 16: Key Expected Changes in Business Structure by Turnover - Global Pharmaceutical Industry
(%), 2013
Table 17: Key Expected Changes In Business Structure by Senior Level Respondents - Global
Pharmaceutical Industry (%), 2013
Table 18: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%),
2013
Table 19: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%),
2013
Table 20: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%),
2013
Table 21: MandA Activity Projections - Global Pharmaceutical Manufacturers' Industry (%), 2010-
2013
Table 22: MandA Activity Projections - Global CROs and CMOs (%), 2010-2013
Table 23: MandA Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010-2013
Table 24: Global Pharmaceutical Industry MandA Activity Projections by Region (%), 2013
Table 25: Global Pharmaceutical Industry MandA Activity Projections by Turnover (%), 2013
Table 26: Global Pharmaceutical Industry MandA Activity Projections by Purchasing Decision
Authority (%), 2013
Table 27: Global Pharmaceutical Industry - Expand Abroad vs. MandA Activity Projections(%), 2013
Table 28: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013
Table 29: Change in Capital Expenditure by Global CROs and CMOs (%), 2013

6. Table 30: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013
Table 31: Global Pharmaceutical Industry - Increase in Capital Expenditure by Region (%), 2013
Table 32: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%),
2013
Table 33: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity
(%), 2013
Table 34: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region
(%), 2013
Table 35: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by
Turnover (%), 2013
Table 36: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013
Table 37: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013
Table 38: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013
Table 39: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%),
2013
Table 40: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%),
2013
Table 41: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries
(%), 2013
Table 42: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countries
by Turnover (%), 2013
Table 43: Global Pharmaceutical Industry - Leading Business Concerns (%), 2010-2013
Table 44: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013
Table 45: Global Pharmaceutical Industry - Leading Business Concerns by Region (%), 2013-2014
Table 46: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses
(%), 2013
Table 47: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%),
2013
Table 48: Global Pharmaceutical Industry - Securing Buyer Business by Turnover (%), 2013
Table 49: Securing Buyer Business in the Global Pharmaceutical Industry - by Purchasing Decision
Authority (%), 2013
Table 50: Annual Marketing Budgets - Global Pharmaceutical Industry Suppliers (%), 2010-2013
Table 51: Annual Marketing Budgets by Region - Global Pharmaceutical Industry Suppliers (%), 2013
Table 52: Annual Marketing Budgets by Turnover - Global Pharmaceutical Industry Suppliers (%),
2013
Table 53: Planned Change in Marketing Expenditure - Global Pharmaceutical Industry Suppliers (%),
2010-2013
Table 54: Planned Change in Marketing Expenditure Levels by Region (%), 2013
Table 55: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2013
Table 56: Planned Change in Marketing Expenditure Levels by Decision Making Authority (%), 2013
Table 57: Change in Marketing Expenditure Levels by Revenue Growth Expectations (%), 2013
Table 58: Future Investment by Media Channels - Global Pharmaceutical Industry Suppliers (%), 2013
Table 59: Planned Investment in Marketing and Sales Technologies - Global Pharmaceutical Industry
Suppliers (%), 2013
Table 60: Key Marketing Aims - Global Pharmaceutical Industry Suppliers (%), 2013
Table 61: Amendments to Marketing Activities - Global Pharmaceutical Industry Suppliers (%), 2013
Table 62: Amendments to Marketing Activities by Company Turnover - Global Pharmaceutical
Industry Suppliers (%), 2013
Table 63: Critical Success Factors - Global Pharmaceutical Industry Suppliers (%), 2010-2013
Table 64: Survey Results - Closed Questions

7. List of Figures
Figure 1: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010-2013
Figure 2: Revenue Growth Optimism in the Global Pharmaceutical Industry by Company Type (%),
2010-2013
Figure 3: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%), 2013
Figure 4: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013
Figure 5: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry
(%), 2013
Figure 6: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry
(%), 2013
Figure 7: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry
(%), 2013
Figure 8: Key Expected Changes in Business Structure by Region - Global Pharmaceutical Industry
(%), 2013
Figure 9: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%),
2013
Figure 10: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%),
2013
Figure 11: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%),
2013
Figure 12: Change in Leading Company Strategies by Turnover - Global Pharmaceutical Industry (%),
2013
Figure 13: MandA Activity Projections - Global Pharmaceutical Industry (%), 2013
Figure 14: MandA Activity Projections - Global Pharmaceutical Manufacturers' Industry (%), 2010-
2013
Figure 15: MandA Activity Projections - Global CROs and CMOs (%), 2010-2013
Figure 16: MandA Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010-2013
Figure 17: Global Pharmaceutical Industry MandA Activity Projections by Region (%), 2013
Figure 18: Global Pharmaceutical Industry MandA Activity Projections by Turnover (%), 2013
Figure 19: Global Pharmaceutical Industry MandA Activity Projections by Purchasing Decision
Authority (%), 2013
Figure 20: Global Pharmaceutical Industry - Expand Abroad Vs MandA Activity Projections (%), 2013
Figure 21: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013
Figure 22: Change in Capital Expenditure by Global CROs and CMOs (%), 2013
Figure 23: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013
Figure 24: Global Pharmaceutical Industry - Increase in Capital Expenditure by Turnover (%), 2013
Figure 25: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%),
2013
Figure 26: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity
(%), 2013
Figure 27: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region
(%), 2013
Figure 28: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by
Turnover (%), 2013
Figure 29: Global Pharmaceutical Industry: Top Ten Growth Regions (%), 2013
Figure 30: Global Pharmaceutical Industry: Top Five Emerging Markets, 2013
Figure 31: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013
Figure 32: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013
Figure 33: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013

8. Figure 34: Global Pharmaceutical Industry - Demand in Emerging Markets by Region (%), 2013
Figure 35: Global Pharmaceutical Industry - Demand in Emerging Markets by Turnover (%), 2013
Figure 36: Global Pharmaceutical Industry - Top Five Developed Regions by Growth (%), 2013
Figure 37: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%),
2013
Figure 38: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%),
2013
Figure 39: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries
(%), 2013
Figure 40: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countries
by Region (%), 2013
Figure 41: Global Pharmaceutical Industry - Top Five Leading Business Concerns, 2013
Figure 42: Global Pharmaceutical Industry - Leading Business Concerns (%), 2013
Figure 43: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013
Figure 44: Global Pharmaceutical Industry - Leading Business Concerns by Turnover (%), 2013-2014
Figure 45: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses
(%), 2013
Figure 46: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%),
2013
Figure 47: Global Pharmaceutical Industry - Securing Buyer Business by Region (%), 2013
Figure 48: Annual Marketing Budgets - Global Pharmaceutical Industry Suppliers (%), 2010-2013
Figure 49: Annual Marketing Budgets by Region - Global Pharmaceutical Industry Suppliers (%), 2013
Figure 50: Annual Marketing Budgets by Turnover - Global Pharmaceutical Industry Suppliers (%),
2013
Figure 51: Planned Change in Marketing Expenditure - Global Pharmaceutical Industry Suppliers (%),
2010-2013
Figure 52: Planned Change in Marketing Expenditure Levels by Region (%), 2013
Figure 53: Planned Change in Marketing Expenditure Levels by Decision Making Authority (%), 2013
Figure 54: Future Investment by Media Channels - Global Pharmaceutical Industry Suppliers (%),
2013
Figure 55: Global Pharmaceutical Industry Suppliers - Investment in Media Channels by Region (%),
2013
Figure 56: Global Pharmaceutical Industry Suppliers - Investment in Media Channels by Turnover
(%), 2013
Figure 57: Planned Investment in Marketing and Sales Technologies - Global Pharmaceutical
Industry Suppliers (%), 2013
Figure 58: Planned Investment in Marketing and Sales Technologies by Region - Global
Pharmaceutical Industry Suppliers (%), 2013
Figure 59: Planned Investment in Marketing and Sales Technologies by Company Turnover - Global
Pharmaceutical Industry Suppliers (%), 2013
Figure 60: Key Marketing Aims - Global Pharmaceutical Industry Suppliers (%), 2013
Figure 61: Key Marketing Aims by Region - Global Pharmaceutical Industry Suppliers (%), 2013
Figure 62: Key Marketing Aims by Turnover - Global Pharmaceutical Industry Suppliers (%), 2013
Figure 63: Amendments to Marketing Activities - Global Pharmaceutical Industry Suppliers (%) , 2013
Figure 64: Amendments to Marketing by Turnover - Global Pharmaceutical Industry Suppliers (%) ,
2013
Figure 65: Critical Success Factors - Global Pharmaceutical Industry Suppliers (%), 2013
Figure 66: Critical Success Factors by Region - Global Pharmaceutical Industry Suppliers (%), 2013
Figure 67: Critical Success Factors by Turnover - Global Pharmaceutical Industry Suppliers (%), 2013